Systemic sclerosis and the risk of tuberculosis

Journal of Rheumatology

Volumn 41, Issue 8, 2014, Pages 1662-1669

  Ou, Shuo Ming ^a,c,d   Fan, Wen Chien ^b,c,d   Cho, Kun Ta ^a,c,d   Yeh, Chiu Mei ^a,c,d   Su, Vincent Yi Fong ^a   Hung, Man Hsin ^a   Chang, Yu Sheng ^c,d,e   Lee, Yi Jung ^a,c,d   Chen, Yung Tai ^a,f   Chao, Pei Wen ^g   Yang, Wu Chang ^a,c,d   Chen, Tzeng Ji ^a   Wang, Wei Shu ^c,d   Tsao, Hsuan Ming ^c,d   Chen, Li Fu ^d   Lee, Fa Yauh ^a,c,d   Liu, Chia Jen ^a,c,d  

^a TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^b Da Chien General Hospital   (Taiwan)

^c Institute of Public Health   (Taiwan)

^d NATIONAL YANG MING UNIVERSITY   (Taiwan)

^e Shuang Ho Hospital   (Taiwan)

^f TAIPEI CITY HOSPITAL   (Taiwan)

^g TAIPEI MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Pulmonary fibrosis; Pulmonary hypertension; Systemic sclerosis; Tuberculosis

Indexed keywords

ADULT; AGE; AGED; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HUMAN; INFECTION RATE; INFECTION RISK; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; PULMONARY HYPERTENSION; RISK FACTOR; SYSTEMIC SCLEROSIS; TAIWAN; TUBERCULOSIS; VERY ELDERLY; CASE CONTROL STUDY; COHORT ANALYSIS; COMPLICATION; FOLLOW UP; INCIDENCE; KAPLAN MEIER METHOD; LONGITUDINAL STUDY; MIDDLE AGED; PROPORTIONAL HAZARDS MODEL; RETROSPECTIVE STUDY;

ADULT; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; KAPLAN-MEIER ESTIMATE; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; RISK FACTORS; SCLERODERMA, SYSTEMIC; TAIWAN; TUBERCULOSIS;

EID: 84905482184     PISSN: 0315162X     EISSN: 14992752     Source Type: Journal    
DOI: 10.3899/jrheum.131125     Document Type: Article

References (46)

1. Gabrielli A, Avvedimento EV, Krieg T. Scleroderma. N Engl J Med 2009;360:1989-2003.
2. Wells AU, Steen V, Valentini G. Pulmonary complications: one of the most challenging complications of systemic sclerosis. Rheumatology 2009;48 Suppl 3:iii40-4.
3. Steen VD, Medsger TA. Changes in causes of death in systemic sclerosis, 1972-2002. Ann Rheum Dis 2007;66:940-4.
4. Jimenez SA, Derk CT. Following the molecular pathways toward an understanding of the pathogenesis of systemic sclerosis. Ann Intern Med 2004;140:37-50.
5. World Health Organization. Global tuberculosis control: surveillance, planning, financing. 2008. [Internet. Accessed June 10, 2014.] Available from: www.who.int/tb/publications/global-report/2008/en/index.html
6. Sgonc R, Wick G. Pro- and anti-fibrotic effects of TGF-beta in scleroderma. Rheumatology 2008;47 Suppl 5:v5-7.
7. Shachor Y, Schindler D, Siegal A, Lieberman D, Mikulski Y, Bruderman I. Increased incidence of pulmonary tuberculosis in chronic interstitial lung disease. Thorax 1989;44:151-3.
8. Inghammar M, Ekbom A, Engstrom G, Ljungberg B, Romanus V, Lofdahl CG, et al. COPD and the risk of tuberculosis-a population-based cohort study. PloS One 2010;5:e10138.
9. Jordan TS, Spencer EM, Davies P. Tuberculosis, bronchiectasis and chronic airflow obstruction. Respirology 2010;15:623-8.
10. Cochrane AL. Tuberculosis and coalworkers' pneumoconiosis. Br J Tuberc Dis Chest 1954;48:274-85.
11. Ahmad QM, Shah IH, Nauman Q, Sameem F, Sultan J. Increased incidence of tuberculosis in patients of systemic sclerosis on dexamethasone pulse therapy: a short communication from Kashmir. Indian J Dermatol 2008;53:24-5.
12. Manz B, Noack-Wiemers F, Mittag M, Haustein UF, Nenoff P. Death due to pulmonary tuberculosis in progressive systemic sclerosis. J Eur Acad Dermatol Venereol 2002;16:647-8.
13. Lin HP, Deng CY, Chou P. Diagnosis and treatment delay among pulmonary tuberculosis patients identified using the Taiwan reporting enquiry system, 2002-2006. BMC Public Health 2009;9:55.
14. Liu CJ, Chang YS, Teng CJ, Chen TJ, Ou SM, Tzeng CH, et al. Risk of extrathymic cancer in patients with myasthenia gravis in Taiwan: a nationwide population-based study. Eur J Neurol 2012;19:746-51.
15. Wu CY, Hu HY, Pu CY, Huang N, Shen HC, Li CP, et al. Pulmonary tuberculosis increases the risk of lung cancer: a population-based cohort study. Cancer 2011;117:618-24.
16. Chang YS, Liu CJ, Ou SM, Hu YW, Chen TJ, Lee HT, et al. Tuberculosis infection in primary Sjogren's syndrome: a nationwide population based study. Clin Rheumatol 2014;33:377-83.
17. Lin HH, Ezzati M, Chang HY, Murray M. Association between tobacco smoking and active tuberculosis in Taiwan: prospective cohort study. Am J Respir Crit Care Med 2009;180:475-80.
18. Baker MA, Lin HH, Chang HY, Murray MB. The risk of tuberculosis disease among persons with diabetes mellitus: a prospective cohort study. Clin Infect Dis 2012;54:818-25.
19. Hou SW, Lee YK, Hsu CY, Lee CC, Su YC. Increased risk of acute pancreatitis in patients with chronic hemodialysis: a 4-year follow-up study. PloS One 2013;8:e71801.
20. Tsan YT, Lee CH, Wang JD, Chen PC. Statins and the risk of hepatocellular carcinoma in patients with hepatitis B virus infection. J Clin Oncol 2012;30:623-30.
21. WHO Collaborating Center for Drugs Statistics Methodology: ATC Index with DDDs 2003. Oslo, Norway, WHO, 2003.
22. Ou SM, Liu CJ, Teng CJ, Lin YT, Chang YS, Chiang SC, et al. Impact of pulmonary and extrapulmonary tuberculosis infection in kidney transplantation: a nationwide population-based study in Taiwan. Transpl Infect Dis 2012;14:502-9.
23. Cowie RL. Silica-dust-exposed mine workers with scleroderma (systemic sclerosis). Chest 1987;92:260-2.
24. Roddy J, Holtby S, Seigel S. Scleroderma concurrent with culture proven tuberculosis in a Japanese Canadian patient. Rheumatol 1996;23:2168-70.
25. Tiukhtin NS, Berlova ZD. [Exudative pleurisy with a tuberculous etiology in a patient with systemic scleroderma]. [Article in Russian] Probl Tuberk 1979; (3): 68-70.
26. Kazak TI, Teriaeva MV, Turintsev BB, Davlinskaia OI. [A case of steroid tuberculosis in systemic scleroderma].[Article in Russian] Probl Tuberk 1996; (2): 57-8.
27. Haustein UF, Anderegg U. Pathophysiology of scleroderma: an update. J Eur Acad Dermatol Venereol 1998;11:1-8.
28. Baron M, Keystone EC, Gladman DD, Lee P, Poplonski L. Lymphocyte subpopulations and reactivity to mitogens in patients with scleroderma. Clin Exp Immunol 1981;46:70-6.
29. Whiteside TL, Kumagai Y, Roumm AD, Almendinger R, Rodnan GP. Suppressor cell function and T lymphocyte subpopulations in peripheral blood of patients with progressive systemic sclerosis. Arthritis Rheum 1983;26:841-7.
30. Behar SM, Porcelli SA. Mechanisms of autoimmune disease induction. The role of the immune response to microbial pathogens. Arthritis Rheum 1995;38:458-76.
31. Minai OA, Dweik RA, Arroliga AC. Manifestations of scleroderma pulmonary disease. Clin Chest Med 1998;19:713-31, viii-ix.
32. Gohari Moghadam K, Gharibdoost F, Parastandechehr G, Salehian P. Assessments of pulmonary involvement in patients with systemic sclerosis. Arch Iran Med 2011;14:22-6.
33. Johnson SR, Granton JT. Pulmonary hypertension in systemic sclerosis and systemic lupus erythematosus. Eur Respir Rev 2011;20:277-86.
34. Deveci F, Akbulut HH, Turgut T, Muz MH. Changes in serum cytokine levels in active tuberculosis with treatment. Mediators Inflamm 2005;2005:256-62.
35. Boom WH, Canaday DH, Fulton SA, Gehring AJ, Rojas RE, Torres M. Human immunity to M. tuberculosis: T cell subsets and antigen processing. Tuberculosis 2003;83:98-106.
36. Sharma S, Bose M. Role of cytokines in immune response to pulmonary tuberculosis. Asian Pac J Allergy Immunol 2001;19:213-9.
37. Steele R, Hudson M, Lo E, Baron M. Clinical decision rule to predict the presence of interstitial lung disease in systemic sclerosis. Arthritis Care Res 2012;64:519-24.
38. Moore OA, Goh N, Corte T, Rouse H, Hennessy O, Thakkar V, et al. Extent of disease on high-resolution computed tomography lung is a predictor of decline and mortality in systemic sclerosis-related interstitial lung disease. Rheumatology 2013;52:155-60.
39. Hou CL, Tsai YC, Chen LC, Huang JL. Tuberculosis infection in patients with systemic lupus erythematosus: pulmonary and extra-pulmonary infection compared. Clin Rheumatol 2008;27:557-63.
40. Zhang L, Wang DX, Ma L. [A clinical study of tuberculosis infection in systemic lupus erythematosus].[Article in Chinese] Zhonghua Nei Ke Za Zhi 2008;47:808-10.
41. Silva DG, Silva BD, Junqueira-Kipnis AP, Rabahi MF. [Tuberculosis in rheumatoid arthritis patients: the difficulty in making the diagnosis of latent infection].[Article in Portuguese] J Bras Pneumol 2010;36:243-51.
42. Baronnet L, Barnetche T, Kahn V, Lacoin C, Richez C, Schaeverbeke T. Incidence of tuberculosis in patients with rheumatoid arthritis. A systematic literature review. Joint Bone Spine 2011;78:279-84.
43. Marie I, Menard JF, Hachulla E, Cherin P, Benveniste O, Tiev K, et al. Infectious complications in polymyositis and dermatomyositis: a series of 279 patients. Semin Arthritis Rheum 2011;41:48-60.
44. Li SY, Chen TJ, Chung KW, Tsai LW, Yang WC, Chen JY, et al. Mycobacterium tuberculosis infection of end-stage renal disease patients in Taiwan: a nationwide longitudinal study. Clin Microbiol Infect 2011;17:1646-52.
45. Nemir RL. Perspectives in adolescent tuberculosis: three decades of experience. Pediatrics 1986;78:399-405.
46. Wong KS, Chiu CH, Huang YC, Lin TY. Childhood and adolescent tuberculosis in northern Taiwan: an institutional experience during 1994-1999. Acta Paediatr 2001;90:943-7.